Skip to main content
Caplight Logo









Cureety

Cureety

Private
DinanHealthcare & Life Scienceshttps://cureety.com/

Last Round

Early Funding

Jan 31, 2022

Total Funding Raised

$6.96M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Cureety is a digital health company that provides a remote patient monitoring platform for oncology patients to help medical teams coordinate care and proactively manage treatment.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Patient Engagement, Telemedicine, Vertical SaaS, Medical AI

Business Model

B2B

Customer Profile

Usage-Based SaaS, Data as a Service

AI Layer

Application

Keywords

remote patient monitoringRPMoncology softwaredigital healthpatient-reported outcomesPROclinical triagemedical device softwareclinical decision supportreal-world dataRWDvertical SaaShealthtechcare managementdigital therapeuticsDTxoncology triage

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cureety Comparables

Compare Cureety with similar companies based on industry and business-model similarity.

Cureety comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Resilience
89%
Careology
84%
Sivan Innovation Ltd.
83%

Cureety Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingJan 31, 2022
Early FundingJan 31, 2022
SeedMar 26, 2020

Key People

Founding team and executive leadership

Pascal Ognibene

Chief Technology Officer

Executive Team

Thierry Sorgnard

Deputy Chief Technology Officer

Executive Team

Cureety Investors

Notable investors and investment history

Cureety investors
InvestorRounds
BpifranceSeed, Early Funding
GroupamaEarly Funding
MBA MutuelleEarly Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 28, 2026

    Grew 24% QoQ, from 78 to 97 employees.

  • Feb 13, 2026

    Grew 17% QoQ, from 66 to 77 employees.

Recent news

Latest coverage and updates

  • acquiresSep 2, 2026

    Cureety acquired Reimagine Care, Inc. on Sep 2nd '26.

Cureety Filings

Explore SEC and related filing metadata, where available.

Cureety filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Cureety's valuation, stock price, and market status.

Is Cureety a public or private company?

Cureety is a private company.

What is the current stock price of Cureety?

Cureety is a private company with no public stock price. No recent secondary market data is available.

How much is Cureety worth (valuation)?

Valuation information for Cureety is not publicly available.

Can I buy Cureety stock?

Cureety shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Cureety's last funding round?

Cureety's most recent funding round was Early Funding on January 31, 2022.

Who are the main investors in Cureety?

Key investors in Cureety include Bpifrance, Groupama, MBA Mutuelle.

Will Cureety IPO soon?

No public IPO plans have been announced for Cureety.

How can I track Cureety secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cureety's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersDinan
Employee Range79
Year Founded2018
Last FundingJan 31, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?